Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Triplebar
AddedFeb 15, 2024
UpdatedJun 18, 2026
Triplebar

Triplebar

Series B

Accelerating biotech research with sustainable solutions, harnessing evolution for complex problem-solving.

HQ
Emeryville, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Triplebar, founded with a mission to accelerate biotechnology research, focuses on sustainable solutions by harnessing the power of evolution for complex problem-solving. The company offers advanced research services in the fields of food and nutrition, as well as biologics. By leveraging cutting-edge technology, Triplebar aims to expedite the discovery process, making it 10,000 times faster than traditional methods. Their market focus includes industries seeking innovative and sustainable biotech solutions.

Notable figures affiliated with Triplebar include experts in biotechnology and sustainability, though specific names are not mentioned. The company has achieved significant milestones in accelerating research timelines and providing scalable solutions to pressing global challenges. Triplebar's impact is evident in its ability to offer rapid, efficient, and sustainable biotech innovations, positioning itself as a key player in the biotechnology sector.

Triplebar - Similar Companies

3Bar Biologics logo

3Bar Biologics

3barbiologics.com

T3S Technologies logo

T3S Technologies

t3sbio.com

Arcadia Science logo

Arcadia Science

arcadiascience.com

BridGene Biosciences logo

BridGene Biosciences

TriMetis Life Sciences logo

TriMetis Life Sciences

BioAnalytics logo

BioAnalytics

Benchling logo

Benchling

benchling.com

Bionl logo

Bionl

bionl.ai

Petri Bio logo

Petri Bio

petribio.com

eBioinformatics logo

eBioinformatics

Boost Biomes logo

Boost Biomes

Vulcan Biologics logo

Vulcan Biologics

TigerGene logo

TigerGene

Boca Biolistics logo

Boca Biolistics

CasTag Biosciences logo

CasTag Biosciences

Triplebar - Quick Facts

Who are Triplebar's competitors?

Companies similar to Triplebar include 3Bar Biologics, T3S Technologies, Arcadia Science and BridGene Biosciences.

When was Triplebar founded?

Triplebar was founded in 2019.

Where is Triplebar's headquarters located?

Triplebar's headquarters is located in Emeryville, CA, US.

When was Triplebar's last funding round?

Triplebar's most recent funding round was for $20M (USD) in October 2023.

How much has Triplebar raised to-date?

As of Oct 25, 2023, Triplebar has raised a total of $20M (USD).

How many employees does Triplebar have?

Triplebar has 45 employees as of Feb 4, 2024.

Triplebar - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
  • Small Business
Main Product
  • Research Services
Tags
  • Biotech
  • Research
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software